GHRP-2: FDA status and clinical evidence

Not FDA-approved

GHRP-2 is not approved by the FDA and has no studies registered on ClinicalTrials.gov as an intervention.

FDA-approved

Registered studies

None

Highest phase

FDA applications

FDA approval status

Status

No approved application

Clinical evidence

No study registered on ClinicalTrials.gov lists GHRP-2 as an intervention. Registration is required for most human trials in the US, so an absence here means research has not been formally registered, not that results are merely unpublished.

Full trial breakdown for GHRP-2 →

Molecular identity

Substance class

Chemical

FDA UNII

E6S6E1F19M

CAS number

158861-67-7

Recorded synonyms

From the FDA Global Substance Registration System, the registry that assigns every substance the FDA tracks a unique identifier.

How to read this. This page reports what federal records say about GHRP-2, nothing more. An FDA approval covers specific uses and doses on a reviewed label. A registered trial records that research was declared, not that it succeeded. A listed patent governs who may sell a drug, not whether it works. None of this is medical advice, and none of it means a compound is safe to use outside a prescription.

Frequently asked questions

Is GHRP-2 FDA-approved?

No. There is no FDA application for GHRP-2 and no registered clinical trial listing it as an intervention.

Why are there no clinical trials for GHRP-2?

Most human research in the US must be registered before it begins. No registration for GHRP-2 means no formal trial has been declared. Laboratory and animal work can still exist, and does not appear in this registry.

Where does the information on this page come from?

Four FDA and NIH sources: Drugs@FDA for approval records, the FDA Orange Book for patents and exclusivity, the FDA Global Substance Registration System for molecular identity, and ClinicalTrials.gov for trial counts. Each is refreshed on a schedule and the date above shows the last refresh.

Sources: Drugs@FDA, FDA Orange Book, FDA Global Substance Registration System and ClinicalTrials.gov. Last refreshed 2026-10-16.